SCHEMBL14309463

SCHEMBL14309463

CN(C(=O)NCc1ccccc1)N1CC(=O)N2[C@@H](c3ccccc3)C(=O)N(Cc3ccc(F)cc3)C[C@@H]21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ ALDH1A1 P00352 5/20 0.38
▸ SCD O00767 1/20 0.38
▸ CACNA1G O43497 1/20 0.37
▸ CACNA1H O95180 1/20 0.37
▸ CACNA1I Q9P0X4 1/20 0.37
▸ SIRT5 Q9NXA8 1/20 0.37
▸ TP53 P04637 2/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ CTSD P07339 1/20 0.35
▸ BACE1 P56817 1/20 0.35
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14309433 0.95 CACNA1G (0.41) KMT2AMEN1ALDH1A1CACNA1GCACNA1H
SCHEMBL13773538 0.92 KMT2A (0.39) KMT2AMEN1ALDH1A1CACNA1GCACNA1H
SCHEMBL14308200 0.92 KMT2A (0.39) KMT2AMEN1ALDH1A1SCDTP53
SCHEMBL13773552 0.90 MEN1 (0.51) KMT2AMEN1ALDH1A1CACNA1GCACNA1H
SCHEMBL14309930 0.90 CLPP (0.39) KMT2AMEN1ALDH1A1CACNA1GCACNA1H
SCHEMBL14310175 0.90 CACNA1I (0.42) KMT2AMEN1ALDH1A1SCDCACNA1G
SCHEMBL14309320 0.90 CLPP (0.46) —
SCHEMBL14503911 0.90 BACE1 (0.39) KMT2AMEN1ALDH1A1TSHRCTSD
SCHEMBL13774093 0.90 SIGMAR1 (0.39) KMT2AMEN1ALDH1A1TSHRGAA
SCHEMBL14504312 0.89 ALDH1A1 (0.40) KMT2AMEN1ALDH1A1CACNA1GCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080009500-A1 Alpha-helix mimetics and methods relating to the treatment of fibrotic disorders INSTITUTE FOR CHEMICAL GENOMICS 2008-01-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009500-A1 Alpha-helix mimetics and methods relating to the treatment of fibrotic disorders COL1A1, COL2A1, PLOD3 KMT2A 4181/4885MEN1 2759/4885ALDH1A1 1525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback